The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings

Peter Ehrenkranz(Gates Foundation), Charles B. Holmes, Andreas Jahn(University of Washington), Michael Odo(Public Health Institute of Malawi), Tom Ellman(Médecins Sans Frontières), Anna Grimsrud(International AIDS Society), Helen Bygrave(Médecins Sans Frontières), Lara Vojnov(World Health Organization), Thokozani Kalua(Ministry of Health), Rose Nyirenda(Ministry of Health), Pascale Ondoa(African Society for Laboratory Medicine), Naoko Doi(Tokushima Municipal Hospital), Solange Baptiste
PLoS Medicine
May 29, 2019
10.1371/journal.pmed.1002820
Cited by 52

Related Papers

WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
|Journal of Clinical Investigation|2009|556
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
|AIDS|2014|375
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
|The Lancet HIV|2016|177
Impact of an Innovative Approach to Prevent Mother-to-Child Transmission of HIV — Malawi, July 2011–September 2012
|PubMed Central|2013|169